FDA and CMS: A Path for Parallel Approvals for Innovative Technologies
01 April 2012
Medical Design
Publication
Authors:
Judith A. Waltz
Medical Design
Partner Judith Waltz authored an article that appeared in Medical Design on April 1, 2012 titled "FDA and CMS: A path for parallel approvals for innovative technologies."
Click here to read the complete article.
Click here to read the complete article.
Authors
Related Services
Industry Teams
Insights
The Future of Illinois Energy Policy: Renewable Energy Set to Expand
17 September 2021
Renewable Energy Outlook
Obviousness Of Method Claim Requires Expectation of Success for Recited Purpose
17 September 2021
PharmaPatents
OpenSea NFT Platform reports insider trading!
17 September 2021
Internet, IT & e-Discovery Blog
7-Eleven Prevails in Employee Misclassification Suit
16 September 2021
Legal News: Distribution & Franchise
Carrie Hoffman Outlines Employer Considerations For 2022 Planning
16 September 2021
Texas Lawyer
Foley Represents Jio, Inc. in Merger with Life360
15 September 2021
Foley Represents TCG Crossover as Lead Investor in $115 Series B Financing for Obsidian Therapeutics
13 September 2021
Vernaglia, Krueger, and Johnston Quoted in Report on Medicare Compliance
13 September 2021
Report on Medicare Compliance
30th Annual Law of Product Distribution & Franchise Seminar
7 & 20 October | 3 November 2021
Webinar
ACI’s Hatch-Waxman and BPCIA Proficiency Series
07 October 2021
Webinar
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
Latino Leaders Magazine presents Top Latinos in Energy
29 September 2021
Dallas, TX